Rare diseases
Investigational molecules
Locations
Helse Stavanger HF, Postboks 8100, 4068 Stavanger, Norway
Stavanger University Hospital HF in Stavanger, Norway specialises in clinical trials of conditions such as Breast cancer female, Cardiac failure, Coronary artery disease, Endocrine ophthalmopathy, and other specialisations. This site conducts important research.
The medical center is at the forefront of neuro-oncology research, focusing on innovative treatments for glioblastoma, a highly aggressive brain tumor. The center's research aims to enhance the median overall survival of patients through novel therapeutic approaches.
By integrating valganciclovir with standard therapies, the center is pioneering efforts to extend patient survival and improve quality of life.
Specializing in the management of viral respiratory tract infections, the center conducts pivotal research on the efficacy and safety of discontinuing antibiotic therapy in patients with viral infections. This research is crucial in addressing antibiotic resistance and optimizing treatment protocols.
The center's work in this area is instrumental in shaping future guidelines for the treatment of viral infections, reducing unnecessary antibiotic use.
Focusing on primary adrenal insufficiency, the center is dedicated to improving patient outcomes through the evaluation of different treatment regimens. The research compares the impact of Plenadren versus conventional cortisone on patients' health-related quality of life.
Through these studies, the center aims to refine treatment approaches, enhancing the overall well-being of patients with adrenal insufficiency.
Clinical trials currently enrolling participants at this site.
Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers
NorwayStudy on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics
NorwayStudy Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease
NorwayContinuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial
NorwayStudy on the Effectiveness of Valganciclovir for Patients with Glioblastoma
NorwayPreventing Heart Failure in Early Breast Cancer Patients Receiving Anthracycline Therapy with Sacubitril and Valsartan (LCZ696)
NorwayStudy on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone
NorwayGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
